TY - JOUR
T1 - A brief overview of synthetic biology research programs and roadmap studies in the United States
AU - Si, Tong
AU - Zhao, Huimin
N1 - Funding Information:
We thank the U.S. National Institutes of Health (GM077596), Roy J. Carver Charitable Trust (13-4257), U.S. Department of Energy (ER65474), Carl R. Woese Institute for Genomic Biology at the University of Illinois at Urbana-Champaign, and the Energy Efficiency & Resources Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) funded by the Ministry of Trade, Industry & Energy, Republic of Korea (20153030091450) for financial support in our development and application of synthetic biology technologies. In addition, we state that there is no conflict of interest.
Funding Information:
We thank the U.S. National Institutes of Health ( GM077596 ), Roy J. Carver Charitable Trust ( 13-4257 ), U.S. Department of Energy ( ER65474 ), Carl R. Woese Institute for Genomic Biology at the University of Illinois at Urbana-Champaign , and the Energy Efficiency & Resources Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) funded by the Ministry of Trade, Industry & Energy, Republic of Korea ( 20153030091450 ) for financial support in our development and application of synthetic biology technologies. In addition, we state that there is no conflict of interest.
Publisher Copyright:
© 2016 The Authors
PY - 2016/12/1
Y1 - 2016/12/1
N2 - The United States is a leading nation in the development of synthetic biology, an emerging engineering discipline to create, control and reprogram biological systems. With strategic investment from its government agencies, the U.S. has established numerous research centers and programs in synthetic biology, enabling significant advances in foundational tool development and practical applications ranging from bioenergy, biomanufacturing, to biomedicine. To maintain its leadership in synthetic biology, U.S, has conducted several roadmap studies to provide strategic visions and action recommendations. Here we will provide a brief overview of the major research programs and roadmap studies of synthetic biology in the U.S.
AB - The United States is a leading nation in the development of synthetic biology, an emerging engineering discipline to create, control and reprogram biological systems. With strategic investment from its government agencies, the U.S. has established numerous research centers and programs in synthetic biology, enabling significant advances in foundational tool development and practical applications ranging from bioenergy, biomanufacturing, to biomedicine. To maintain its leadership in synthetic biology, U.S, has conducted several roadmap studies to provide strategic visions and action recommendations. Here we will provide a brief overview of the major research programs and roadmap studies of synthetic biology in the U.S.
UR - http://www.scopus.com/inward/record.url?scp=85017700006&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85017700006&partnerID=8YFLogxK
U2 - 10.1016/j.synbio.2016.08.003
DO - 10.1016/j.synbio.2016.08.003
M3 - Review article
C2 - 29062951
AN - SCOPUS:85017700006
SN - 2405-805X
VL - 1
SP - 258
EP - 264
JO - Synthetic and Systems Biotechnology
JF - Synthetic and Systems Biotechnology
IS - 4
ER -